Home
Who we are
Pipeline
News
Contact
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Our mission is to develop essential medicines to improve
care and support of children suffering from orphan diseases.
Latest news and reports
Latest news and report
11 March 2020
ORPHELIA announces the appointment of Laurent Martin as Chief Pharmaceutical Affairs Officer
Read more
28 January 2020
Orphelia Pharma fund raising
Read more
7 January 2020
Launch of Kigabeq® in France
Read more
6 January 2020
ORPHELIA Pharma will be present at Toulouse for the thirtieth SFNP congress
Read more
10 December 2019
Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma
Read more
26 November 2019
Granting of the Marketing Authorisation for Ivozall
Read more
29 October 2019
ORPHELIA Pharma will be present at CPhI in Frankfurt
Read more
29 October 2019
License and distribution agreement for Kigabeq in the United Kingdom
Read more
